Report #2883395

Received Jan 29, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Not recovered
Vaccinated: Oct 28, 2025
Onset: Oct 30, 2025
Days to onset: 2
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
UNK	VACCINE NOT SPECIFIED (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	Z003579	OT / RA

Symptoms (6)

ArthralgiaInjection site painInjection site swellingLymph node painNeck painPain

Symptom narrative

ARTHRALGIA; INJECTION SITE SWELLING; NECK PAIN; LYMPH NODE PAIN; INJECTION SITE PAIN; PAIN; Information has been received via Vaccine Adverse Event Reporting System (agency # 2870660-1) on 28-Jan-2026. This spontaneous report refers to a 59-year-old female patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications were not reported. On 28-Oct-2025, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) lot # Z003579 has been verified to be a valid lot number, expiration date not reported, but upon internal validation established as 07-Sep-2026, (Dose 1), administered by intramuscular route in the right arm, for prophylaxis. On 30-Oct-2025, the patient experienced injection site swelling, neck pain, lymph node pain, injection site pain, arthralgia and pain. At the reporting time, the patient had not recovered from the events. The causal relationship between all the events and Pneumococcal 21-valent Conjugate Vaccine was not provided.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : , Index date : 2026-01-28 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : 2870660 , Central date : 2026-01-28 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :